NEXMOS
NEXMOS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-12-17
Address:
Yongsin, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.nexmos.com
Total Employee:
1+
Status:
Active
Contact:
070-5138-9863
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible SSL By Default LetsEncrypt Mobile Non Scaleable Content Euro Google Google Cloud Pound Sterling Japanese Yen CentOS
Similar Organizations
Singapore Institute of Advanced Medicine Holdings
This company is a cutting-edge technology in radiological services.
Target RWE
Target RWE is a provider of Biotechnology services.
More informations about "NEXMOS"
NEXMOS-๋ฅ์ค๋ชจ์ค
Nexmos๋ ํญ์ฐํ ๋ฌผ์ง์ ํน์ด์ ์ผ๋ก ๋ฐ์ํ๋ DNA Meta-platform Aptaminยฎ๋ฅผ ํ์ฉํ์ฌ ์ง์์ ์ธ ์น๋ฃ์ ๊ฐ๋ฐ๋ฐ ์ํ๊ฐ๋ฐ์ ์งํํ๊ณ ์์ต๋๋ค. View moreSee details»
NEXMOS-๋ฅ์ค๋ชจ์ค
Nexmos is an innovative, biotechnology R&D company with a brand-new DNA meta-platform protected by global intellectual properties. Founded in 2014, the company has developed DNA โฆSee details»
NEXMOS-๋ฅ์ค๋ชจ์ค
Based On The Worldโs first DNA Aptamer Patent, Becoming A Global Therapeutics and Healthcare Market Leader. โImprovement of Vascular Dementiaโ SCI-grade thesis published in โฆSee details»
Nexmos (Korea) - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Nexmos (Korea). Use the PitchBook Platform to explore the full profile.See details»
NEXMOS - Crunchbase Company Profile & Funding
NEXMOS is a provider of biotechnology and healthcare services. There is no recent news or activity for this profile. Where is NEXMOS's headquarters? NEXMOS is located in Yongsin, โฆSee details»
Nexmos Company Profile - Office Locations, Competitors, โฆ
Nexmos is a company engaged in the development of Aptamin, aptamer-based technology in a variety of applications. Its formulations extend aptamer applications into cosmetics, โฆSee details»
Nexmos - VentureRadar
Website: http://www.nexmos.com/ Develops innovative biotechnology solutions for human wellness and beauty, focusing on a proprietary DNA platform and blood-brain barrier โฆSee details»
NEXMOS-๋ฅ์ค๋ชจ์ค
Anti-aging, Strengthening immune system, Prevention of cancer, arteriosclerosis, myocardial infarction and stroke.See details»
NEXMOS - Crunchbase
NEXMOS is a provider of biotechnology and healthcare services.See details»
Nexmos - Company Profile - Tracxn
Oct 26, 2024ย ยท Nexmos - Aptamer based technologies. Founded by Nelson Son in the year 2014. Nexmos has 192 competitors.See details»
NEXMOS-๋ฅ์ค๋ชจ์ค
์ธ๊ณ ์ต์ด์ DNA ์ํ๋จธ ์์ฉํ๋ฅผ ์์์ผ๋ก ๊ธ๋ก๋ฒ ํฌ์ค์ผ์ด ์์ฅ ์ง์ถ. Intellectual Property Status.See details»
Nexmos - Overview, News & Similar companies | ZoomInfo.com
Sep 27, 2021ย ยท Nexmos contact info: Phone number: +82 7051380964 Website: www.nexmos.com What does Nexmos do? (About Nexmos, Inc.) Nexmos is a South Korea โฆSee details»
Nexmos CEO and Key Executive Team | Craft.co
Nexmos's Co-CEO & CTO is Michael Kim. Other executives include Eric Sohn, CSO. See the full leadership team at Craft.See details»
Base Pair Biotechnologies, Inc. and Nexmos, Inc. Create the First โฆ
Dec 28, 2016ย ยท The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation โฆSee details»
2016: A Landmark Year in Nexmoโs Evolution - LinkedIn
Jan 10, 2017ย ยท Beyond the technological and cultural synergies, joining a mature company has accelerated Nexmoโs organizational growth. We have added 75 new employees to our team โฆSee details»
NEXMOS-๋ฅ์ค๋ชจ์ค
NXP031 with aptamin C technology reduces oxidative stress, neuroinflammation and disease-causing toxic protein plaques (Amyloid-ฮฒ, alpha-synuclein) in the brain to protect nerve cells.See details»
NXP-031 - Drug Targets, Indications, Patents - Synapse
NXP-031, Initially developed by Nexmos, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases,Endocrinology and Metabolic Disease, Active โฆSee details»
Nexmo's 2018 in Review: Video, Next-Gen Messaging, GDPR
Jan 28, 2019ย ยท In 2018 we evolved our platform to enable more intelligent interactions across more channels, including video and social chat apps. Along the way, we built and launched โฆSee details»
NEXMOS-๋ฅ์ค๋ชจ์ค
ROS Scavenger Boosting Aptamer is an Antioxidant Complexed DNA Aptamer that delivers specific antioxidants into cells in an active form (Active Delivery), and maximizes antioxidant โฆSee details»
NEXMOS-๋ฅ์ค๋ชจ์ค
Immune activity therapeutics activate the body's immune cells to treat various diseases, including cancer. Aptamin C complex effectively prevents and treats respiratory infection viruses based โฆSee details»